FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1848804918> ?p ?o ?g. }

• W1848804918 endingPage "60" @default.
• W1848804918 startingPage "4953" @default.
• W1848804918 abstract "Bombesin/gastrin releasing peptide (BN/GRP) is a growth factor for small cell lung cancer (SCLC). The receptor (R) for BN/GRP is overexpressed on SCLC cells and other solid tumors. BN/GRP and its receptor form an autocrine loop to promote tumor growth. We developed a novel immunotherapeutic approach targeting cell surface BN/GRP-R on SCLC cells and an immune trigger molecule on host immune effector cells to direct immune effector cells to SCLC cells and mediate targeted cancer cell destruction. Targeted immunotherapy combined with chemotherapy enhanced cell killing.We designed a synthetic BN/GRP antagonist (Antag 2) and constructed a bispecific molecule (BsMol), H22xAntag 2 (humanized monoclonal antibody) for FcgammaRI. We tested the binding of the BsMol to several SCLC cell lines, its ability to mediate cytotoxicity of SCLC by IFN-gamma-activated human monocytes with chemotherapy, and BsMol-mediated immunotherapy in an animal model of SCLC human xenograft.Common chemotherapy (cisplatin, etoposide, and paclitaxel) inhibited thymidine uptake into SCLC cells in a dose-dependent pattern. Antibody-dependent cellular cytotoxicity mediated by the BsMol inhibited thymidine uptake into SCLC cells and was largely dependent on E:T cell ratio. When SCLC cells were treated with antibody-dependent cellular cytotoxicity followed by exposure to chemotherapy agents an additional 25-40% inhibition of thymidine uptake into SCLC cells was observed consistently. With BsMol and IFN-gamma-activated human monocytes, tumor burdens were reduced significantly in immunodeficient mice bearing human SCLC xenografts.Combined chemotherapy and immunotherapy targeting BN/GRP-R with a BsMol significantly enhances targeted SCLC cell killing." @default.
• W1848804918 created "2016-06-24" @default.
• W1848804918 creator A5005627824 @default.
• W1848804918 creator A5011317679 @default.
• W1848804918 creator A5021999626 @default.
• W1848804918 creator A5036394378 @default.
• W1848804918 creator A5065883808 @default.
• W1848804918 creator A5015945268 @default.
• W1848804918 date "2003-10-15" @default.
• W1848804918 modified "2023-09-23" @default.
• W1848804918 title "Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer." @default.
• W1848804918 cites W1512974202 @default.
• W1848804918 cites W1537449868 @default.
• W1848804918 cites W1581554099 @default.
• W1848804918 cites W1600235544 @default.
• W1848804918 cites W1847826686 @default.
• W1848804918 cites W1896751847 @default.
• W1848804918 cites W1933350662 @default.
• W1848804918 cites W1964445130 @default.
• W1848804918 cites W1979710105 @default.
• W1848804918 cites W1992319616 @default.
• W1848804918 cites W1996702303 @default.
• W1848804918 cites W2019895529 @default.
• W1848804918 cites W2030136627 @default.
• W1848804918 cites W2031956553 @default.
• W1848804918 cites W2032423298 @default.
• W1848804918 cites W2058015212 @default.
• W1848804918 cites W2065571239 @default.
• W1848804918 cites W2084748765 @default.
• W1848804918 cites W2086680571 @default.
• W1848804918 cites W2089512767 @default.
• W1848804918 cites W2094627540 @default.
• W1848804918 cites W2097318216 @default.
• W1848804918 cites W2100033601 @default.
• W1848804918 cites W2109694492 @default.
• W1848804918 cites W2114974083 @default.
• W1848804918 cites W2154027407 @default.
• W1848804918 cites W2167549601 @default.
• W1848804918 cites W2168926834 @default.
• W1848804918 cites W2190031288 @default.
• W1848804918 cites W2318605753 @default.
• W1848804918 cites W2376870910 @default.
• W1848804918 cites W2409630476 @default.
• W1848804918 cites W2463724811 @default.
• W1848804918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14581370" @default.
• W1848804918 hasPublicationYear "2003" @default.
• W1848804918 type Work @default.
• W1848804918 sameAs 1848804918 @default.
• W1848804918 citedByCount "14" @default.
• W1848804918 countsByYear W18488049182016 @default.
• W1848804918 countsByYear W18488049182019 @default.
• W1848804918 countsByYear W18488049182022 @default.
• W1848804918 crossrefType "journal-article" @default.
• W1848804918 hasAuthorship W1848804918A5005627824 @default.
• W1848804918 hasAuthorship W1848804918A5011317679 @default.
• W1848804918 hasAuthorship W1848804918A5015945268 @default.
• W1848804918 hasAuthorship W1848804918A5021999626 @default.
• W1848804918 hasAuthorship W1848804918A5036394378 @default.
• W1848804918 hasAuthorship W1848804918A5065883808 @default.
• W1848804918 hasConcept C109316439 @default.
• W1848804918 hasConcept C118303440 @default.
• W1848804918 hasConcept C121608353 @default.
• W1848804918 hasConcept C126322002 @default.
• W1848804918 hasConcept C128240485 @default.
• W1848804918 hasConcept C159654299 @default.
• W1848804918 hasConcept C170493617 @default.
• W1848804918 hasConcept C202751555 @default.
• W1848804918 hasConcept C203014093 @default.
• W1848804918 hasConcept C2776998989 @default.
• W1848804918 hasConcept C2777701055 @default.
• W1848804918 hasConcept C2778448772 @default.
• W1848804918 hasConcept C502942594 @default.
• W1848804918 hasConcept C55493867 @default.
• W1848804918 hasConcept C71924100 @default.
• W1848804918 hasConcept C86803240 @default.
• W1848804918 hasConcept C8891405 @default.
• W1848804918 hasConcept C96232424 @default.
• W1848804918 hasConceptScore W1848804918C109316439 @default.
• W1848804918 hasConceptScore W1848804918C118303440 @default.
• W1848804918 hasConceptScore W1848804918C121608353 @default.
• W1848804918 hasConceptScore W1848804918C126322002 @default.
• W1848804918 hasConceptScore W1848804918C128240485 @default.
• W1848804918 hasConceptScore W1848804918C159654299 @default.
• W1848804918 hasConceptScore W1848804918C170493617 @default.
• W1848804918 hasConceptScore W1848804918C202751555 @default.
• W1848804918 hasConceptScore W1848804918C203014093 @default.
• W1848804918 hasConceptScore W1848804918C2776998989 @default.
• W1848804918 hasConceptScore W1848804918C2777701055 @default.
• W1848804918 hasConceptScore W1848804918C2778448772 @default.
• W1848804918 hasConceptScore W1848804918C502942594 @default.
• W1848804918 hasConceptScore W1848804918C55493867 @default.
• W1848804918 hasConceptScore W1848804918C71924100 @default.
• W1848804918 hasConceptScore W1848804918C86803240 @default.
• W1848804918 hasConceptScore W1848804918C8891405 @default.
• W1848804918 hasConceptScore W1848804918C96232424 @default.
• W1848804918 hasIssue "13" @default.
• W1848804918 hasLocation W18488049181 @default.
• W1848804918 hasOpenAccess W1848804918 @default.

• next